Matches in SemOpenAlex for { <https://semopenalex.org/work/W4283325050> ?p ?o ?g. }
- W4283325050 endingPage "4819" @default.
- W4283325050 startingPage "4809" @default.
- W4283325050 abstract "Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the seventh member of the coronavirus family that can infect humans. Recently, more contagious and pathogenic variants of SARS-CoV-2 have been continuously emerging. Clinical candidates with high efficacy and ready availability are still in urgent need. To identify potent anti-SARS-CoV-2 repurposing drugs, we evaluated the antiviral efficacy of 18 selective estrogen receptor modulators (SERMs) against SARS-CoV-2 infection. Six SERMs exhibited excellent anti-SARS-CoV-2 effects in Vero E6 cells and three human cell lines. Clomifene citrate, tamoxifen, toremifene citrate, and bazedoxifene acetate reduced the weight loss of hamsters challenged with SARS-CoV-2, and reduced hamster pulmonary viral load and interleukin-6 expression when assayed at 4 days postinfection. In particular, bazedoxifene acetate was identified to act on the penetration stage of the postattachment step via altering cholesterol distribution and endosome acidification. And, bazedoxifene acetate inhibited pseudoviruses infection of original SARS-CoV-2, Delta variant, Omicron variant, and SARS-CoV. These results offer critical information supporting bazedoxifene acetate as a promising agent against coronaviruses." @default.
- W4283325050 created "2022-06-24" @default.
- W4283325050 creator A5000369163 @default.
- W4283325050 creator A5001544952 @default.
- W4283325050 creator A5003315105 @default.
- W4283325050 creator A5005116981 @default.
- W4283325050 creator A5019646027 @default.
- W4283325050 creator A5021293751 @default.
- W4283325050 creator A5028294527 @default.
- W4283325050 creator A5034673563 @default.
- W4283325050 creator A5038524316 @default.
- W4283325050 creator A5046528451 @default.
- W4283325050 creator A5048826252 @default.
- W4283325050 creator A5060925527 @default.
- W4283325050 creator A5066855208 @default.
- W4283325050 creator A5087357150 @default.
- W4283325050 date "2022-07-01" @default.
- W4283325050 modified "2023-09-26" @default.
- W4283325050 title "Antiviral efficacy of selective estrogen receptor modulators against SARS‐CoV‐2 infection in vitro and in vivo reveals bazedoxifene acetate as an entry inhibitor" @default.
- W4283325050 cites W2051062943 @default.
- W4283325050 cites W2102537321 @default.
- W4283325050 cites W2176155893 @default.
- W4283325050 cites W2804243913 @default.
- W4283325050 cites W2885069553 @default.
- W4283325050 cites W2904382879 @default.
- W4283325050 cites W2910185744 @default.
- W4283325050 cites W2946367097 @default.
- W4283325050 cites W3009912996 @default.
- W4283325050 cites W3015998678 @default.
- W4283325050 cites W3036887118 @default.
- W4283325050 cites W3041776517 @default.
- W4283325050 cites W3081862895 @default.
- W4283325050 cites W3084601775 @default.
- W4283325050 cites W3087689951 @default.
- W4283325050 cites W3092266552 @default.
- W4283325050 cites W3094129930 @default.
- W4283325050 cites W3117619525 @default.
- W4283325050 cites W3127556689 @default.
- W4283325050 cites W3128335178 @default.
- W4283325050 cites W3136390341 @default.
- W4283325050 cites W3144949987 @default.
- W4283325050 cites W3158239484 @default.
- W4283325050 cites W3172812363 @default.
- W4283325050 cites W3201877532 @default.
- W4283325050 cites W3205588626 @default.
- W4283325050 cites W3211673200 @default.
- W4283325050 cites W4200062769 @default.
- W4283325050 cites W4200273456 @default.
- W4283325050 cites W4200585723 @default.
- W4283325050 cites W4205170082 @default.
- W4283325050 cites W4210866043 @default.
- W4283325050 cites W4283325050 @default.
- W4283325050 doi "https://doi.org/10.1002/jmv.27951" @default.
- W4283325050 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35733297" @default.
- W4283325050 hasPublicationYear "2022" @default.
- W4283325050 type Work @default.
- W4283325050 citedByCount "2" @default.
- W4283325050 countsByYear W42833250502022 @default.
- W4283325050 countsByYear W42833250502023 @default.
- W4283325050 crossrefType "journal-article" @default.
- W4283325050 hasAuthorship W4283325050A5000369163 @default.
- W4283325050 hasAuthorship W4283325050A5001544952 @default.
- W4283325050 hasAuthorship W4283325050A5003315105 @default.
- W4283325050 hasAuthorship W4283325050A5005116981 @default.
- W4283325050 hasAuthorship W4283325050A5019646027 @default.
- W4283325050 hasAuthorship W4283325050A5021293751 @default.
- W4283325050 hasAuthorship W4283325050A5028294527 @default.
- W4283325050 hasAuthorship W4283325050A5034673563 @default.
- W4283325050 hasAuthorship W4283325050A5038524316 @default.
- W4283325050 hasAuthorship W4283325050A5046528451 @default.
- W4283325050 hasAuthorship W4283325050A5048826252 @default.
- W4283325050 hasAuthorship W4283325050A5060925527 @default.
- W4283325050 hasAuthorship W4283325050A5066855208 @default.
- W4283325050 hasAuthorship W4283325050A5087357150 @default.
- W4283325050 hasBestOaLocation W42833250502 @default.
- W4283325050 hasConcept C121608353 @default.
- W4283325050 hasConcept C159047783 @default.
- W4283325050 hasConcept C2522874641 @default.
- W4283325050 hasConcept C2777176818 @default.
- W4283325050 hasConcept C2777637070 @default.
- W4283325050 hasConcept C2777944059 @default.
- W4283325050 hasConcept C530470458 @default.
- W4283325050 hasConcept C54355233 @default.
- W4283325050 hasConcept C86803240 @default.
- W4283325050 hasConcept C89138240 @default.
- W4283325050 hasConcept C98274493 @default.
- W4283325050 hasConceptScore W4283325050C121608353 @default.
- W4283325050 hasConceptScore W4283325050C159047783 @default.
- W4283325050 hasConceptScore W4283325050C2522874641 @default.
- W4283325050 hasConceptScore W4283325050C2777176818 @default.
- W4283325050 hasConceptScore W4283325050C2777637070 @default.
- W4283325050 hasConceptScore W4283325050C2777944059 @default.
- W4283325050 hasConceptScore W4283325050C530470458 @default.
- W4283325050 hasConceptScore W4283325050C54355233 @default.
- W4283325050 hasConceptScore W4283325050C86803240 @default.
- W4283325050 hasConceptScore W4283325050C89138240 @default.
- W4283325050 hasConceptScore W4283325050C98274493 @default.
- W4283325050 hasIssue "10" @default.